JSPR
Jasper Therapeutics Inc
0.6091$
+4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | 100.0% | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 5.0% | – | 2.6% | – | – | – | – | 21.6% | – | 4.0% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 100.0% | – | -5.0% | – | -2.6% | – | – | – | – | -21.6% | – | -4.0% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 77.4% | – | 107.8% | – | 77.5% | – | – | – | – | 761.1% | – | 674.2% | – | – | – | 1,684.2% | – | – | – | – | – | – | – | |
| – | – | – | – | 32.1% | – | 43.4% | – | 43.4% | – | – | – | – | 259.3% | – | 189.6% | – | – | – | 469.6% | – | – | – | – | – | – | – | |
| – | – | – | – | 109.5% | – | 151.2% | – | 120.9% | – | – | – | – | 1,020.4% | – | 863.8% | – | – | – | 2,153.7% | – | – | – | – | – | – | – | |
| – | – | – | – | -109.5% | – | -151.2% | – | -120.9% | – | – | – | – | -1,020.4% | – | -863.8% | – | – | – | -2,153.7% | – | – | – | – | – | – | – | |
| – | – | – | – | 61.3% | – | 0.1% | – | 100.0% | – | – | – | – | – | – | 15.3% | – | – | – | 430.8% | – | – | – | – | – | – | – | |
| – | – | – | – | -170.7% | – | -51.2% | – | -20.9% | – | – | – | – | -920.4% | – | -808.0% | – | – | – | -2,071.6% | – | – | – | – | – | – | – | |
| – | – | – | – | 122.6% | – | -2.0% | – | -100.0% | – | – | – | – | -106.2% | – | 93.2% | – | – | – | 4.6% | – | – | – | – | – | – | – | |
| – | – | – | – | -170.7% | – | -51.2% | – | -20.9% | – | – | – | – | -920.4% | – | -808.0% | – | – | – | -2,071.6% | – | – | – | – | – | – | – | |
| – | – | – | – | -109.1% | – | -49.1% | – | -18.8% | – | – | – | – | -904.7% | – | -794.2% | – | – | – | -2,050.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.